Atlas Trials

A Pharmacokinetic and Bioequivalence Study of Savolitinib Tablets in Healthy Chinese Male Volunteers

Clinical trial NCT03860948 · COMPLETED

Trial details

NCT number
NCT03860948
Sponsor
Hutchison Medipharma Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2019-04-16
Primary completion
2019-05-02
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.